Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Pharmaceutical Business Review
Return to: PBR Home | Suppliers

Heightened FDA Enforcement for Sterility Issuesin Pharma Biotech with NSF

Published 13 June 2017 | By NSF Health Sciences Pharma Biotech PBR

NSF analysed all of the warning letters issued to pharma and biologic manufacturers for sterility issues since 2015. This white paper provides detailed insight into our analysis. It includes relative charts and a table with a summary of the regulations cited by the FDA as well as recommendations for closing your compliance gaps.

Available Downloads

Heightened FDA Enforcement for Sterility Issuesin Pharma Biotech with NSF